<div id="readability-page-1"><ul><li>Nuclear, Pharma &amp; Travel Buybacks: Confident or Cautious Signals?</li></ul><p>Eli Lilly and Company, Abbott Laboratories,  and AbbVie are the three Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly traded companies that research, develop, manufacture, and sell prescription drugs, vaccines, and other therapeutic products. They include large integrated drugmakers as well as smaller biotechnology firms focused on specific therapies. For investors these stocks are often driven by clinical trial results, regulatory approvals, patent expirations and pricing/policy changes, creating both binary upside potential and elevated volatility and risk. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days.</p><div><p><span></span><span>Get <strong>Eli Lilly and Company</strong> alerts:</span></p></div><h2>Eli Lilly and Company (LLY)</h2><p>Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.</p><ul><li>Lilly's Next Empire: A $10 Billion Bet on AI and Neuroscience</li></ul><p>Read Our Latest Research Report on LLY</p><h2>Abbott Laboratories (ABT)</h2><p>Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon.</p><ul><li>Merck Just Made a Big Bet on a New Cancer Growth Engine </li></ul><p>Read Our Latest Research Report on ABT</p><h2>AbbVie (ABBV)</h2><p>AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers.</p><p>Read Our Latest Research Report on ABBV</p><h2>Recommended Stories</h2><ul><li>MarketBeat's Top Five Stocks to Own in April 2026</li><li>With Nike Shares Near a 12-Year Low, Is Now the Time to Be Brave?</li><li>3 Different Fintech Giants: Turnaround, Stability, or Risky Bet?</li><li>Microsoft’s Copilot Problem Isn’t What You Think</li><li>3 Surprising S&amp;P 500 Outperformers of 2026</li><li>Russell 2000 Tracking for New Highs: What’s Next for ETF Traders?</li></ul><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Eli Lilly and Company Right Now?</h2><p>Before you consider Eli Lilly and Company, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eli Lilly and Company wasn't on the list.</p><p>While Eli Lilly and Company currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

ARKG

<p>Eli Lilly, Abbott Laboratories, and AbbVie are highlighted as top pharmaceutical stocks to watch, according to MarketBeat. These companies are involved in developing and selling various healthcare products, including diabetes medications and treatments for autoimmune diseases. Their stocks are influenced by clinical trials, regulatory changes, and market dynamics, making them both promising and volatile investments. Despite a Moderate Buy rating for Eli Lilly, analysts suggest other stocks may offer better investment opportunities.</p>

Best Pharmaceutical Stocks To Follow Now - April 12th